Sign in Subscribe
Cancer research

AI for Equitable Diagnostics in Women's Health: Research Highlights Need for Infrastructure, Workforce Development, and Community Engagement

Strategic Insights

— 2 min read

A new publication in the British Medical Journal highlights the potential of artificial intelligence (AI) to significantly improve access to life-saving diagnostics for women's health in low-resource settings. However, the study, conducted by an international team of researchers led by Professor Nina Linder, emphasizes that investments in infrastructure, workforce development, and community engagement are crucial for the responsible scaling of AI in this context. The researchers implemented an AI-supported cytology system in Kenya and Tanzania, demonstrating that it can expand access to screening where traditional pathology services are limited.

Key Takeaways:

  • The study, published in the British Medical Journal, demonstrates that AI-supported diagnostics can significantly expand access to screening where traditional pathology services are limited.
  • The researchers highlight the need for investment in infrastructure, supply chains, and community trust to ensure the reliable deployment of AI in real-world settings.
  • The study shows that AI-enabled cytology can reduce reliance on on-site pathologists, speed up diagnostic turnaround times, and expand screening coverage.
  • Challenges such as power interruptions and reagent variability can affect the reliability of AI results, emphasizing the importance of investments in infrastructure and integration into local health systems.
  • AI alone is not enough; it must be embedded within functioning health systems and supported by community trust to benefit women in underserved areas.
  • The team's next steps involve scaling AI-supported diagnostics across broader health programs and conditions, while continuing to strengthen local health systems and community engagement.

Statistics:

  • The study highlights that cervical cancer has recently surpassed maternal mortality as a leading cause of death among women globally.
  • The number of preventable deaths due to cervical cancer is a critical issue, emphasizing the urgency of the research.
  • The study was conducted by a team led by Professor Nina Linder, in close collaboration with principal investigators from Kenya, Tanzania, and Sweden.
  • The research team implemented an AI-supported cytology system in Kenya and Tanzania, with results demonstrating its potential to expand access to screening.

Sources:

  • Linder N., Nyirenda D., Martensson A., Kaingu H., Ngasala B., Lundin J. (2025) AI-supported diagnostic innovations for impact in global women's health. British Medical Journal, 2025;391:e086009. doi: https://doi-org.sdpl.idm.oclc.org/10.1136/bmj-2025-086009
  • University of Helsinki news release, October 10. AI for Equitable Diagnostics in Women's Health.
  • The British Medical Journal Collection on Women's Health Innovation, developed in partnership with the Gates Foundation.
  • Original publication, AI-supported diagnostic innovations for impact in global women's health.

Read more